IAN KINNAIRD: Open Payments
NPI 1215663323 · MENTOR, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,913 in 177 payments from 26 companies in 2025. Trend: 2023 $801 · 2024 $2,577 · 2025 $2,913
Food & beverage: $2,863Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $513 |
| Janssen Biotech, Inc. | 15 | $278 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $254 |
| PFIZER INC. | 13 | $241 |
| Aimmune Therapeutics, Inc. | 18 | $240 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $161 |
| Madrigal Pharmaceuticals | 7 | $152 |
| QOL Medical, LLC | 8 | $147 |
| Phathom Pharmaceuticals, Inc. | 23 | $144 |
| Regeneron Healthcare Solutions, Inc. | 4 | $119 |
Products named: TREMFYA, DUPIXENT, VOWST, VELSIPITY, RINVOQ, REZDIFFRA, Sucraid, VOQUEZNA.
Industry payments across OH — which companies pay providers there.
